Workshop

"ECONOMICS OF IMMUNIZATION"

22-23 August 2002, Oslo

• Dr. Tore Godal, Executive Secretary, GAVI, Switzerland

Overview presentation – What do we know about the economics of immunization? Powerpoint – 91k

• Prof. Dean Jamison

Investing in immunization: The diversity of country situations Powerpoint – 408k

• Mr. Jonas Gahr Støre, Director and Chairman of the Board, ECON, Norway

What kind of economic information do decision-makers need for resource allocation?

• a) Developing country perspective
• H.E. Dr. Pascoal M. Mocumbi, Prime Minister, Mozambique
• H.E. Mr. Donald Kaberuka, Minister of Finance, Rwanda
• b) Donor perspective Powerpoint – 34k
• Ms Marion Kelly, DFID, U.K.

Economic benefits from investing in child health and immunization Powerpoint – 1062k

• Prof. David Canning, Department of Economics, Queen's University, Belfast, U.K.

Finance for health in low-income countries: Findings of the Commission on Macroeconomics and Health

• Prof. Alan Tait, University of Kent at Canterbury, U.K.

GAVI Financing Task Force: GAVI Financial Sustainability plans and process Powerpoint – 225k; GAVI Immunization Financing Database Powerpoint – 525k

• Mr. Dan Kress, Abt Associates, U.S.A.

CHOICE: a new WHO database to provide cost-effectiveness data for all major health interventions

• Dr. Dan Chishom, WHO, Switzerland

Catalytic vaccine financing Powerpoint – 101k

• Mr. Raj Shah, The Gates Foundation, USA

Health system approaches to increase coverage Powerpoint – 175k

• Dr. Sam Adjei's presentation delivered by Tore Godal

Challenges in reaching higher coverage, from a McKinsey perspective PDF – 93k

• Mr. Michael Conway, McKinsey Consulting, U.S.A.

Consider and discuss research directions

• Prof. David Canning, Dr. Richard Bumgarner, Dr. Sigrun Mogedal

Conclusions and next steps

Download Adobe Acrobat (Required to read PDF documents)